Since Isis' inception in 1989, the Company has worked diligently
to build antisense expertise in all phases of drug discovery and
development. Each of Isis' prospective partners comes with different
needs and goals, and the Company leverages its expertise to structure
a collaboration to meet partner's objectives. Isis currently engages
in partnerships in the following areas:
- Antisense Drug Discovery
- Antisense Drug Development
- Ibis Biosciences, Inc.
- Intellectual Property Licenses
- Satellite Companies
